4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-064897
Chief Executive Officer acquired 40,510 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2020-12-18 | Option exercise | +12,236 | $4.75 | $58,121 | 2,517,473 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2020-12-18 | Option exercise | +28,274 | $6.15 | $173,885 | 2,545,747 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2020-12-18 | Option exercise · Common Stock (right to buy) | −12,236 | 828,307 | D | ||
| Anzalone Christopher Richard Chief Executive Officer | 2020-12-18 | Option exercise · Common Stock (right to buy) | −28,274 | 800,033 | D | ||
Loading xslF345X03/doc4.xml…